News for 'Sun Pharmaceuticals'

Sensex, Nifty settle almost flat in lacklustre trade

Sensex, Nifty settle almost flat in lacklustre trade

Rediff.com11 Mar 2025

From the Sensex pack, IndusInd Bank, Infosys, Bajaj Finserv, Mahindra & Mahindra, Zomato, Hindustan Unilever, Power Grid, Axis Bank, UltraTech Cement, Adani Ports, and Tata Consultancy Services were among the laggards. On the other hand, Sun Pharmaceuticals, ICICI Bank, Bharti Airtel, HCL Technologies, Maruti Suzuki India, Larsen & Toubro, Reliance Industries, Kotak Mahindra Bank and Titan were the gainers.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Sensex falls below 73K on relentless FII selling

Sensex falls below 73K on relentless FII selling

Rediff.com4 Mar 2025

From the Sensex pack, Nestle India, HCL Technologies, Tech Mahindra, Bharti Airtel, Titan, Infosys, Asian Paints, NTPC, Bajaj Finserv and Sun Pharmaceuticals were among the laggards. State Bank of India, IndusInd Bank, Zomato, Power Grid, ICICI Bank, Tata Motors, Mahindra & Mahindra, Tata Consultancy Services and Adani Ports were the gainers.

S&P cuts India's FY26 GDP growth forecast to 6.5%

S&P cuts India's FY26 GDP growth forecast to 6.5%

Rediff.com25 Mar 2025

S&P Global Ratings on Tuesday cut India's GDP growth projections to 6.5 per cent for the next fiscal as it expects that economies in the APAC region will feel the strain of rising US tariffs and pushback on globalisation. In its Economic Outlook for Asia-Pacific (APAC), S&P said despite these external strains, it expects domestic demand momentum to remain solid in most emerging-market economies.

Sensex rallies 610 points to reclaim 74,000

Sensex rallies 610 points to reclaim 74,000

Rediff.com6 Mar 2025

From the Sensex pack, Asian Paints, NTPC, Reliance Industries, Tata Steel, Bajaj Finserv, Hindustan Unilever, Sun Pharmaceuticals, Adani Ports & SEZ, Axis Bank, Tata Consultancy Services, Titan and Bajaj Finance were the major gainers. Tech Mahindra, Kotak Mahindra Bank, Zomato, Tata Motors, and IndusInd Bank were the laggards.

Be Prepared! Heat Waves Coming!

Be Prepared! Heat Waves Coming!

Rediff.com1 Apr 2025

'The intensity and frequency of heatwaves will be much higher than in previous years over Punjab, Haryana, Rajasthan, Gujarat, Madhya Pradesh and Odisha.'

US reciprocal tariffs to have limited impact on India: S&P

US reciprocal tariffs to have limited impact on India: S&P

Rediff.com19 Feb 2025

S&P Global Ratings on Wednesday said the impact of the US reciprocal tariff will be limited on India as the economy is domestically oriented with less reliance on exports. YeeFarn Phua, Director, Sovereigns and International Public Finance Ratings, Asia-Pacific S&P Global also said India will clock a 6.7-6.8 per cent GDP growth over the next two years.

Mutual Funds Emerge As Financiers For M&A Deals

Mutual Funds Emerge As Financiers For M&A Deals

Rediff.com6 Feb 2025

'Growth for some companies has been hard to come by and this is a smart way to get there.'

How Tamil Nadu Is Becoming A Global Hub

How Tamil Nadu Is Becoming A Global Hub

Rediff.com2 Apr 2025

After Chennai, it is Coimbatore, Madurai, and Tiruchirappalli, that are emerging as manufacturing hubs. Coimbatore is India's top Tier-II city in terms of the number of GCCs, according to a report by Cushman & Wakefield.

Tariffs, earnings key for FII flows after Rs 1.54 trillion pullout in FY25

Tariffs, earnings key for FII flows after Rs 1.54 trillion pullout in FY25

Rediff.com25 Mar 2025

Global funds have pulled out Rs 1.54 trillion from domestic stocks in fiscal 2024 - 25 (FY25), the highest-ever outflow recorded so far, according to the data compiled by Business Standard. The last time the global funds exited Indian shores in droves was back in 2022, when they sold a net Rs 1.41 in the backdrop of Covid-19.

EXPLAINED: Trump's reciprocal tariffs

EXPLAINED: Trump's reciprocal tariffs

Rediff.com3 Apr 2025

Here is a list of Q & As to explain these issues and implications of the US move.

Trump tariffs: 'This is not a tax cut, this is a tax hike'

Trump tariffs: 'This is not a tax cut, this is a tax hike'

Rediff.com3 Apr 2025

"These latest so-called 'Liberation Day' tariffs are reckless and self-destructive, inflicting financial pain on Illinois at a time when people are already struggling to keep their small businesses afloat and put food on the table."

Sensex gains 115 points on buying in IT, consumer stocks

Sensex gains 115 points on buying in IT, consumer stocks

Rediff.com23 Jan 2025

From the Sensex pack, UltraTech Cement, Mahindra & Mahindra, Sun Pharmaceutical, Zomato, Tech Mahindra, Tata Steel, Tata Motors, Titan, ITC and Bajaj Finance were the major gainers. In contrast, Kotak Mahindra Bank, HCL Technologies, PowerGrid, Reliance Industries, State Bank of India, Hindustan Unilever, IndusInd Bank, Nestle India and Axis Bank were among the laggards.

Rupee Slide: Tough Times For Overseas Corporate Debt

Rupee Slide: Tough Times For Overseas Corporate Debt

Rediff.com16 Jan 2025

Raising overseas debt has become prohibitively expensive due to the depreciating rupee.

'2025 Is Year To Keep Expectations Low'

'2025 Is Year To Keep Expectations Low'

Rediff.com12 Feb 2025

'Stay disciplined, and remain invested.' 'Volatile times are the best to invest in structural opportunities at the right price.'

'Trump's Hopes For India's Tariff Cuts Too Ambitious'

'Trump's Hopes For India's Tariff Cuts Too Ambitious'

Rediff.com2 Apr 2025

'I certainly hope the two can avoid a trade war and believe they will.' 'I expect some in India will push for retaliatory tariffs if the Trump administration applies significant reciprocal tariffs.'

Selling in HDFC Bank, RIL drag markets down

Selling in HDFC Bank, RIL drag markets down

Rediff.com3 Mar 2025

From the Sensex pack, Reliance Industries, Bajaj Finserv, HDFC Bank, Adani Ports, Maruti Suzuki India, Axis Bank, Hindustan Unilever, Sun Pharmaceuticals and Asian Paints were among the laggards. Reliance Industries fell the most by 2.38 per cent to close at Rs 1,171.10 apiece.

Trump 2.0: Tough Navigation Lies Ahead For India

Trump 2.0: Tough Navigation Lies Ahead For India

Rediff.com12 Feb 2025

'As the global economy undergoes significant transformations in 2025, India's ability to navigate the complexities of trade wars, financial realignments, and emerging blocs will be pivotal,' explain Harsh V Pant and Soumya Bhowmik.

Sensex, Nifty rebound on buying in Infosys, HDFC Bank

Sensex, Nifty rebound on buying in Infosys, HDFC Bank

Rediff.com22 Jan 2025

Among Sensex shares, Infosys, Tata Consultancy Services, Tech Mahindra, Sun Pharmaceutical, Bajaj Finserv, HCL Technologies, Bajaj Finance, HDFC Bank, IndusInd Bank and Kotak Mahindra Bank were among the gainers. Tata Motors, PowerGrid, Axis Bank, State Bank of India, NTPC, Tata Steel and Adani Ports were the major laggards.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

'US May Demand Not Just Tariff Cuts But...'

'US May Demand Not Just Tariff Cuts But...'

Rediff.com5 Mar 2025

I'...additional concessions, such as opening government procurement, reducing agricultural subsidies, weakening patent protections, and allowing unrestricted data flows -- demands India has resisted for decades.'

US drug shortage a shot in the arm for Indian pharmaceutical companies

US drug shortage a shot in the arm for Indian pharmaceutical companies

Rediff.com26 Jun 2023

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a

Oscar-Nominated Movies Rule OTT

Oscar-Nominated Movies Rule OTT

Rediff.com28 Feb 2025

Women power, rebellious love, shady godmen, love triangles and more on OTT. Sukanya Verma lists everything coming up on OTT this week.

There will be some pain: Trump's message to Americans

There will be some pain: Trump's message to Americans

Rediff.com3 Feb 2025

United States President Donald Trump on Sunday criticised the trade deficits that the US has with Canada, Mexico, China, and argued that America should no longer 'subsidise' other countries, and urged businesses to manufacture domestically to avoid tariffs.

Two Indian students killed in car crash in Ireland; 2 critical

Two Indian students killed in car crash in Ireland; 2 critical

Rediff.com2 Feb 2025

Two Indian students in their 20s were killed and two others injured in a car crash in County Carlow, southern Ireland. The Indian Embassy in Dublin issued a condolence message on social media. The four friends had been sharing a house in the local area and had recently finished third-level education at South East Technological University (SETU) in Carlow.

Women, Your Birth Number Can Help You Succeed

Women, Your Birth Number Can Help You Succeed

Rediff.com7 Mar 2025

By understanding the elements that rule your birth number, you can learn how to enhance your professional journey, improve your work life and grow in your career.

Budget focuses on domestic consumption amid global uncertainties

Budget focuses on domestic consumption amid global uncertainties

Rediff.com4 Feb 2025

The Budget 2025-26 meets the expectations of fiscal consolidation, maintaining capital expenditure, and boosting consumption through tax cuts.

US pledges to boost technology ties with India

US pledges to boost technology ties with India

Rediff.com14 Feb 2025

Artificial Intelligence, innovation and next-generation technologies figured prominently during the high-stakes discussion between Prime Minister Narendra Modi and US President Donald Trump at the White House, as the two sides announced transformative measures, including the US-India TRUST initiative, roadmap on accelerating AI infrastructure and INDUS Innovation, to boost tech ties.

10 Stocks That Soared While Market Sank

10 Stocks That Soared While Market Sank

Rediff.com24 Mar 2025

The stocks are largely from sectors such as chemicals, finance and cement, which struggled earlier but the worse seems to be behind them.

Factors that will support credit access of India Inc in FY26

Factors that will support credit access of India Inc in FY26

Rediff.com13 Jan 2025

Fitch Ratings on Monday said India's steady GDP growth outlook, improved banking sector's financial health and expected interest-rate cuts in 2025 will support credit access for corporates in FY26.

Have Indian DNA, many of us have Sanskrit names: Indonesian Prez

Have Indian DNA, many of us have Sanskrit names: Indonesian Prez

Rediff.com27 Jan 2025

'Everybody knows when I hear Indian music, I start dancing'

India Inc profits crawl as sales stay sluggish

India Inc profits crawl as sales stay sluggish

Rediff.com24 Feb 2025

Corporate India's struggle with subdued revenue and earnings growth persisted in the October-December quarter of 2024-25 (Q3FY25). The combined net sales (gross interest earnings for lenders) of listed companies grew in single digits for the seventh consecutive quarter, while their combined net profit rose by a single digit for the third straight quarter.

Dabba Cartel Review: High Five!

Dabba Cartel Review: High Five!

Rediff.com28 Feb 2025

Dabba Cartel's reluctant black comedy in the body of a crime thriller starts out interestingly enough to accomplish its Narcos: Thane aspirations, notes Sukanya Verma.

Trump vows tariffs on nations that 'harm' US; names India, China

Trump vows tariffs on nations that 'harm' US; names India, China

Rediff.com28 Jan 2025

Earlier, Trump has already talked about slapping "100 per cent tariffs" on the BRICS grouping, a bloc that includes India as well.

Trump's Reciprocal Tariffs Bite Into Apple's India Growth Plans

Trump's Reciprocal Tariffs Bite Into Apple's India Growth Plans

Rediff.com12 Mar 2025

Apple's ambitious strategy to expand iPhone exports, shift more production from China to India at a faster pace, and grow its domestic market hits a Trump-sized roadblock.

Over 500 kg cocaine worth Rs 5000 cr recovered in Gujarat

Over 500 kg cocaine worth Rs 5000 cr recovered in Gujarat

Rediff.com13 Oct 2024

With this, 1,289 kilograms of cocaine and 40 kilograms of hydroponic Thailand marijuana worth Rs 13,000 crore have been seized by the law enforcement agencies within a fortnight in Delhi and Gujarat, sources said.

Budget 2025: What is costlier, what is cheaper

Budget 2025: What is costlier, what is cheaper

Rediff.com2 Feb 2025

Here is a list of items set to become cheaper and costlier.

Pharma companies fight fakes with smart packaging

Pharma companies fight fakes with smart packaging

Rediff.com10 Oct 2024

Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private investigation agencies. The stakes are high, as counterfeit medicines not only harm consumers but also tarnish the reputation of leading brands.

Rupee depreciation may exacerbate market sell-off if downtrend continues

Rupee depreciation may exacerbate market sell-off if downtrend continues

Rediff.com21 Jan 2025

Rupee depreciation, if it continues, will likely pull the markets down further. Since September 2024, the rupee has declined by 3.1 per cent, the Nifty has dropped by 8.5 per cent during the same period, and the Sensex has fallen by 7.3 per cent. If the decline continues, markets will need to brace for more pain as it could push foreign portfolio investors (FPIs) to exit their positions faster than anticipated.

How To Apply For A Rs 1 Lakh MBBS Scholarship

How To Apply For A Rs 1 Lakh MBBS Scholarship

Rediff.com20 Nov 2024

Under this scholarship, first-year MBBS students from government colleges are eligible to receive monetary assistance of up to Rs 1,00,000 per year for a duration of up to 4.5 years, covering academic expenses incurred towards their MBBS degree.